BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.
Ren Y, Huang SH, Patel S, Alberto WDC, Magat D, Ahimovic D, Macedo AB, Durga R, Chan D, Zale E, Mota TM, Truong R, Rohwetter T, McCann CD, Kovacs CM, Benko E, Wimpelberg A, Cannon C, Hardy WD, Bosque A, Bollard CM, Jones RB.
Ren Y, et al. Among authors: mccann cd.
J Clin Invest. 2020 May 1;130(5):2542-2559. doi: 10.1172/JCI132374.
J Clin Invest. 2020.
PMID: 32027622
Free PMC article.